Exploratory Study on the Efficacy of Zebutinib as Maintenance Therapy Following CAR-T Cell Therapy in Patients With Non-Hodgkin B-Cell Lymphoma
Clinical trial NCT07198373 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07198373
- Sponsor
- Beijing GoBroad Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-09-20
- Primary completion
- 2027-12-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.